Nico Gariboldi

With approximately 550 people in its workforce, and the goal of reaching 650 by 2025, the Pfizer Center for Digital Innovation (CDI) in Thessaloniki runs over 250 global projects, leveraging artificial intelligence and machine learning to quantum technology, with the aim of even contributing to the acceleration of new drug discovery.

Pfizer's investment in Thessaloniki is mainly an investment in human capital, says Nico Gariboldi, senior director at the pharmaceutical company's Global Digital and Technology Hub. Speaking to Kathimerini, he describes the timetable of the American pharmaceutical corporation's investment in the northern Greek city and the profile of scientists currently staffing the digital hub.